You are here

  • Home
  • Archive
  • Volume 93, Issue 7
  • Increases in gonorrhoea incidence and GUM clinic waiting times: are we in a vicious circle like the late 1990s and early 2000s, but now exacerbated by drug resistance?

Article Text

Article menu
Download PDFPDF
Clinical
Letter
Increases in gonorrhoea incidence and GUM clinic waiting times: are we in a vicious circle like the late 1990s and early 2000s, but now exacerbated by drug resistance?
  1. Peter J White1,2,3
  1. 1 MRC Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology, Imperial College London School of Public Health, London, UK
  2. 2 NIHR Health Protection Research Unit in Modelling Methodology, Department of Infectious Disease Epidemiology, Imperial College London School of Public Health, London, UK
  3. 3 Modelling and Economics Unit, National Infection Service, Public Health England, London, UK
  1. Correspondence to Dr Peter J White, Department of Infectious Disease Epidemiology, Imperial College School of Public Health, Norfolk Place, London, W2 1PG, UK; p.white{at}imperial.ac.uk

https://doi.org/10.1136/sextrans-2017-053242

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    I read the paper of Foley et al (Inequalities in access to genitourinary medicine clinics in the UK: results from a mystery shopper survey. Sex Trans Infect Sex Online First: 04 April 2017) with concern.

    Delays in treating symptomatic patients typically indicate insufficient service capacity, creating a vicious circle where delayed (or lack of) treatment causes onward transmission, increasedincidence and continuing unmet treatment need.1 Increased treatment capacity (complemented by condom promotion and other prevention activity) is …

    View Full Text

    Footnotes

    • Contributors This letter was conceived and written by its author.

    • Funding The author thanks the Medical Research Council (grant MR/K010174/1) and the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Modelling Methodology at Imperial College London in partnership with Public Health England (PHE) (grant HPRU-2012-10080) for funding.

    • Disclaimer The views expressed are those of the authors and not necessarily those of the Department of Health, MRC, NHS, NIHR, or Public Health England.

    • Competing interests None declared.

    • Ethics approval Not required.

    • Provenance and peer review Not commissioned; internally peer reviewed.

    Linked Articles